Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations

被引:173
作者
Kaukonen, AM [1 ]
Boyd, BJ [1 ]
Porter, CJH [1 ]
Charman, WN [1 ]
机构
[1] Monash Univ, Victorian Coll Pharm, Dept Pharmaceut, Parkville, Vic 3052, Australia
基金
芬兰科学院;
关键词
dissolution; drug absorption; lipid-based drug delivery; lipid digestion;
D O I
10.1023/B:PHAM.0000016282.77887.1f
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of this study was to characterize the solubilization and precipitation characteristics of a range of poorly watersoluble drugs during digestion of either long-chain or medium-chain triglyceride (TG) lipid formulations. Methods. TG solution formulations of five selected drugs ( griseofulvin, diazepam, danazol, cinnarizine, and halofantrine) were digested in vitro and drug distribution/solubilization behavior in the resulting digests assessed. Results. For the less lipophilic drugs, the mass of drug dissolved in either medium or long-chain TG was low and the drugs partitioned rapidly into the aqueous digestion phase. For the higher log P drugs, drug transfer to the aqueous phase was limited by accumulation in undigested long-chain TG. In contrast, medium-chain TG was digested completely producing a dispersed aqueous phase that was capable, at least in the case of the high log P drugs, of supporting supersaturated drug concentrations. Conclusions. The solubilization behavior of lipophilic drugs on digestion of simple TG lipid formulations is a function of the lipophilicity of the drug ( which dictates the drug dose and the partitioning behavior), the nature of the colloidal phases produced on digestion of the different formulation lipids, and the kinetics of drug transfer between the digesting formulation and the colloidal phases produced.
引用
收藏
页码:245 / 253
页数:9
相关论文
共 27 条
[1]  
Anderson B D., 1999, Bulletin technique-Gattefosse Report, P11
[2]   Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum [J].
Armand, M ;
Borel, P ;
Pasquier, B ;
Dubois, C ;
Senft, M ;
Andre, M ;
Peyrot, J ;
Salducci, J ;
Lairon, D .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1996, 271 (01) :G172-G183
[3]  
Avdeef A., 1996, LIPOPHILICITY DRUG A, P109
[4]   REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOR EVALUATING THE LIPOPHILICITY OF PHARMACEUTICAL SUBSTANCES WITH IONIZATION UP TO LOG PAPP = 8 [J].
BELSNER, K ;
PFEIFER, M ;
WILFFERT, B .
JOURNAL OF CHROMATOGRAPHY, 1993, 629 (02) :123-134
[5]  
BOYD BJ, 2003, J PHARM SCI
[6]   Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs [J].
Gershanik, T ;
Benita, S .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :179-188
[7]   PHYSICAL-CHEMICAL BEHAVIOR OF DIETARY AND BILIARY LIPIDS DURING INTESTINAL DIGESTION AND ABSORPTION .2. PHASE-ANALYSIS AND AGGREGATION STATES OF LUMINAL LIPIDS DURING DUODENAL FAT DIGESTION IN HEALTHY ADULT HUMAN-BEINGS [J].
HERNELL, O ;
STAGGERS, JE ;
CAREY, MC .
BIOCHEMISTRY, 1990, 29 (08) :2041-2056
[8]   SIMPLIFIED LIQUID-CHROMATOGRAPHY ASSAY FOR THE QUANTITATION OF HALOFANTRINE AND DESBUTYLHALOFANTRINE IN PLASMA AND IDENTIFICATION OF A DEGRADATION PRODUCT OF DESBUTYLHALOFANTRINE FORMED UNDER ALKALINE CONDITIONS [J].
HUMBERSTONE, AJ ;
CURRIE, GJ ;
PORTER, CJH ;
SCANLON, MJ ;
CHARMAN, WN .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (03) :265-272
[9]  
Humberstone AJ, 1997, ADV DRUG DELIVER REV, V25, P103, DOI 10.1016/S0169-409X(96)00494-2
[10]   BETA-CYCLODEXTRIN DERIVATIVES, SBE4-BETA-CD AND HP-BETA-CD, INCREASE THE ORAL BIOAVAILABILITY OF CINNARIZINE IN BEAGLE DOGS [J].
JARVINEN, T ;
JARVINEN, K ;
SCHWARTING, N ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (03) :295-299